• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    CompoSecure Continues to Strengthen Board of Directors with the Appointment of Dr. Krishna Mikkilineni

    10/21/24 4:05:00 PM ET
    $CMPO
    Finance: Consumer Services
    Finance
    Get the next $CMPO alert in real time by email

    SOMERSET, N.J., Oct. 21, 2024 (GLOBE NEWSWIRE) -- CompoSecure, Inc. (NASDAQ:CMPO), a leader in metal payment cards, security, and authentication solutions, is pleased to announce the appointment of Dr. Krishna Mikkilineni to its Board of Directors ("Board"), effective today. Dr. Mikkilineni brings a wealth of experience in operations and technology, along with a proven ability to deliver success for leading global organizations such as Honeywell.

    "With the addition of Dr. Mikkilineni we continue to strengthen our world-class Board of Directors," said Jon Wilk, President and CEO of CompoSecure. "His exceptional business acumen and extensive global expertise will enhance our ability to drive growth, accelerate operational excellence, and expand our international opportunities."

    Dr. Mikkilineni currently serves as General Partner of a deep tech venture fund and a startup accelerator, roles he has held since 2019, and in which he has been instrumental in funding and growing 30 technology-driven startup companies. Prior to May 2019, Dr. Mikkilineni served in various roles of increasing seniority at Honeywell International, Inc. for over 33 years, including as global Chief Technology Officer, a role he held for nine years, and as global Integrated Supply Chain Officer and Chief Information Officer, roles he held for six years. Prior to that, Dr. Mikkilineni established Honeywell's engineering operation in India eventually growing the global engineering force to over 11,000 with half focused on software. Dr. Mikkilineni received his Ph.D. in electrical and computer engineering from the University of Florida.

    "We are thrilled to welcome Krishna to our Board of Directors," said David Cote, Executive Chairman of the CompoSecure Board of Directors. "His experience leading high-performing organizations will be a great asset as we seek to unlock CompoSecure's potential in an effort to drive both short-term and long-term value for shareholders."

    "I am honored to join CompoSecure's Board of Directors at such an exciting time," said Dr. Krishna Mikkilineni. "I look forward to collaborating with the other Board members and the management team to help CompoSecure further strengthen its position as a market leader and enable this business to grow in high impact areas leveraging my background."

    Dr. Mikkilineni replaces Niloo Razi Howe who recently resigned from the Board due to personal reasons. CompoSecure expresses its sincere appreciation to Niloo for her dedicated service and invaluable contributions to the company.

    About CompoSecure

    Founded in 2000, CompoSecure (NASDAQ:CMPO) is a technology partner to market leaders, fintechs and consumers enabling trust for millions of people around the globe. The company combines elegance, simplicity and security to deliver exceptional experiences and peace of mind in the physical and digital world. CompoSecure's innovative payment card technology and metal cards with Arculus security and authentication capabilities deliver unique, premium branded experiences, enable people to access and use their financial and digital assets, and ensure trust at the point of a transaction. For more information, please visit www.composecure.com and www.GetArculus.com.

    Corporate Contact

    Anthony Piniella

    Head of Corporate Communications, CompoSecure

    (908) 898-8887

    [email protected]

    Investor Relations Contact

    Sean Mansouri, CFA

    Elevate IR

    (720) 330-2829

    [email protected]



    Primary Logo

    Get the next $CMPO alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Q&A

    New
    • Who has been appointed to the Board of Directors of CompoSecure?

      Dr. Krishna Mikkilineni has been appointed to the Board of Directors of CompoSecure, effective October 21, 2024.

    • What significant experience does Dr. Mikkilineni bring to CompoSecure?

      Dr. Mikkilineni previously held various senior roles at Honeywell International, including global Chief Technology Officer for nine years.

    • What impact is Dr. Mikkilineni's appointment expected to have on CompoSecure?

      The appointment is expected to enhance CompoSecure's ability to drive growth, operational excellence, and expand international opportunities.

    • Who did Dr. Mikkilineni replace on the Board of Directors?

      Dr. Mikkilineni replaces Niloo Razi Howe, who resigned from the Board for personal reasons.

    • What are Dr. Mikkilineni's goals for joining CompoSecure's Board of Directors?

      Dr. Mikkilineni aims to strengthen CompoSecure's market position and help drive business growth leveraging his expertise.

    Recent Analyst Ratings for
    $CMPO

    DatePrice TargetRatingAnalyst
    12/18/2024$20.00Buy
    TD Cowen
    7/10/2024$9.00Buy
    BofA Securities
    6/27/2024$12.00Buy
    Lake Street
    2/13/2024$7.00Buy
    The Benchmark Company
    12/18/2023$7.00 → $6.00Overweight → Neutral
    JP Morgan
    6/13/2023$13.00Buy
    Berenberg
    3/3/2023$15.00Buy
    Compass Point
    12/14/2022$9.00Buy
    BTIG Research
    More analyst ratings